Search results for

Speaking at Managing IP’s US Patent Forum last week in Washington DC, Lisa Kattan of the US International Trade Commission (ITC) gave tips on how to better take advantage of the proceedings. One bit of advice – don’t treat it as if it’s standard litigation

The recent decision of the Kenyan High Court in Weetabix Limited v Manji Food Industries Ltd is noteworthy. First, trade mark judgments are rare in Kenya. Second, because it deals with a range of issues – likelihood of confusion, a family of marks, well-known marks and passing off. Third, because the Court managed to reach a decision which, although not unreasonable, may seem a bit odd to some.

The Supreme People's Court of the People's Republic of China (SPC) issued the Draft Judicial Interpretation on Application of Laws in Trial of Behaviour Preservation Cases Involving Intellectual Property and Competition Disputes (Draft JI) on February 26 2015 and is open for public comment until March 30.

The possibility to recover costs in IP cases can be an important consideration in your litigation strategy. Correspondents in Brazil, Canada, China, France, Germany, India, the United Kingdom and United States answer six questions about their jurisdictions

Backlogs and delay in the examination and grant of patents have been commonplace in India for several years now. In 2013 Nitto Denko, a patent applicant facing significant delays in the registration of its patents, approached the Delhi High Court on the issue of delayed patent examination. As per Rule 24B of the Patent Rules, 2003, the first examination report (FER) should be sent to the applicant within six months from the date of request of examination or six months from date of publication whichever is later. This time-frame is almost never adhered to by the Patent Office because of a shortage of human resources.

A Greek entity registered in its name the domain name www.alibaba.info. Alibaba, the globally well-known e-commerce Chinese company filed a complaint against the above-mentioned domain name holder on the basis of UDRP rules before the Asian Domain Name Dispute Resolution Center. This action failed.

On February 6 2015, the Food and Drug Administration (FDA) issued Memorandum Circular No 2015-003 reiterating the FDA's disallowance of the phrase "No Approved Therapeutic Claim" in any form of advertisement, promotion, sponsorship activities or materials concerning food/dietary supplements, as embodied in FDA Administrative Order No 2010-008.

On January 20 2015, a Memorandum of Understanding (MoU) was signed between the Intellectual Property Office of Singapore (IPOS) and Cambodia's Ministry of Industry and Handicraft (MIH). Under the terms of the agreement, applicants can soon enjoy ease of application for patents and industrial designs in Cambodia and Singapore by filing in either country.

Understanding the “average consumer” is the key to resolving many questions related to trade mark law. But who is he or she?

Life science companies face unique patent issues, for example concerning relief, exemptions and supplementary protection. Bert Oosting, Andreas von Falck, Stanislas Roux-Vaillard, Stephen Bennett and Daniel Brook examine how these questions will be addressed in the proposed UPC